TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, prov

VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in...

Related Keywords

Sweden ,United States ,American ,Anders Kristensson ,Prnewswire Tikomed ,Celentyx Ltd ,Cold Spring Harbor Laboratory ,Yellow Fever ,Amyotrophic Lateral Sclerosis ,Traumatic Brain Injury ,Latin American ,